GCI, AnVil To Probe Arthritis Gene Expression | GenomeWeb

NEW YORK, April 24-AnVil and Genomics Collaborative will be working together on a pilot project to apply new data analysis and visualization systems to microarray data, AnVil said in a statement today.

In the project, AnVil will apply its visualization and analysis tools to GCI's DNA microarray data.

The partnership is designed to help GCI identify gene expression patterns that could suggest new drug targets for inflammatory disease, especially rheumatoid arthritis.

AnVil, based in Burlington, Mass., is a privately held bioinformatics company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Biology this week: comparative genomics study of Aspergillus, genetic variation in indigenous African cattle, and more.

Some people who harbor genetic variants associated with disease show no signs and may give insight into the continuum of symptoms, Spectrum reports.

Some 57 snow monkeys at a Japanese zoo were found to be rhesus macaque hybrids, which are banned in Japan.

British researchers say they've been removed from EU grant applications, according to the Guardian.